on 12 Jul 2022
Last Applicant/ Owned by
Babraham Research Campus
Cambridge
CB223AT
Serial Number
90726980 filed on 21st May 2021
Registration Number
6785291 registered on 12th Jul 2022
Correspondent Address
Peter Sloane
Filing Basis
No Filing Basis
Disclaimer
"THERAPEUTICS"
Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system, the immune system, the metabolic system, the musculo-skeletal system, the cardiovascular system, the respiratory system, infectious diseases, obesity, incontinence, cancer, inflammation and inflammatory diseases, auto-immune diseases, blood diseases, tumors, multiple sclerosis, ulcRead More
Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in biotechnological product development
Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system, the immune system, the metabolic system, the musculo-skeletal system, the cardiovascular system, the respiratory system, infectious diseases, obesity, incontinence, cancer, inflammation and inflammatory diseases, auto-immune diseases, blood diseases, tumors, multiple sclerosis, ulcerative colitis, arthritis, and skin disease
Biotechnology research; Pharmaceutical research and development; Testing of pharmaceuticals
No 90726980
No Service Mark
No 10200/315018
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
12th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
12th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
21st Jun 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
21st Jun 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
21st Jun 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
26th Apr 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
26th Apr 2022 | PUBLISHED FOR OPPOSITION |
06th Apr 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
18th Mar 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
07th Mar 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |